ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,471.05
      1.16%
      US Tech 100
      18,213.60
      1.48%
      Dow Jones
      40,829.59
      1.20%
      Brent Oil
      71.78
      0.09%
      Bitcoin
      56,874.69
      -0.26%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Crinetics Pharmaceuticals Inc (CRNX) Quote

      Crinetics Pharmaceuticals Inc

      Crinetics Pharmaceuticals Inc (CRNX)

      NASDAQ
      52.24
      1.85
      (3.67%)
      Closed September 09 4:00PM
      Delayed by 15 minutes
      52.24
      0.05
      (0.10%)
      After Hours: 7:50PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      52.24
      Bid
      49.93
      Ask
      54.11
      Volume
      614,216
      50.6636 Day's Range 53.12
      24.75 52 Week Range 55.78
      Market Cap
      4.181B
      Previous Close
      50.39
      Open
      51.06
      Last Trade
      37
      @
      52.24
      Last Trade Time
      Financial Volume
      $ 32,096,481
      VWAP
      52.256
      Average Volume (3m)
      692,019
      Shares Outstanding
      80,035,610
      Dividend Yield
      -
      PE Ratio
      -19.47
      Earnings Per Share (EPS)
      -2.68
      Revenue
      4.01M
      Net Profit
      -214.53M

      About Crinetics Pharmaceuticals Inc

      Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.crinetics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was $50.39. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of $ 24.75 to $ 55.78.

      Crinetics Pharmaceuticals currently has 80,035,610 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is $4.03 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.47.

      Ask ADVFN Intelligence (AI)

      CRNX Latest News

      More News

      FeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd.

      11 hours ago

      Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

      SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization...

      August 29 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      August 28 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      August 26 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 14 2024
      Edgar (US Regulatory)

      Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2024, the Compensation Committee of Crinetics’ Board of Directors...

      August 12 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      August 12 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

      Paltusotine NDA Submission in Acromegaly On Track for 2024 Topline Results from Phase 2 Studies of Atumelnant in Congenital Adrenal Hyperplasia and Additional Data for Phase 2 for ACTH-Dependent...

      August 08 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1-1.8782870022553.2454.1249.6744671651.31654542CS
      44.549.517819706547.755.747.0747051552.36540057CS
      127.1215.78014184445.1255.7841.0169201949.96315127CS
      2610.2624.440209623641.9855.7837.4480525447.60661953CS
      5227.158108.27685192625.08255.7824.75100617337.8671846CS
      15627.94114.97942386824.355.7815.2356774230.4435172CS
      26035.66215.0784077216.5855.7810.6339275928.59596708CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NBSTWNewbury Street Acquisition Corporation
      $ 0.08
      (59.05%)
      		10.3k
      SMMTSummit Therapeutics Inc
      $ 19.13
      (55.91%)
      		47.84M
      ALGSAligos Therapeutics Inc
      $ 19.50
      (55.88%)
      		489.87k
      SINTSiNtx Technologies Inc
      $ 4.3242
      (53.34%)
      		68.7M
      TILInstill Bio Inc
      $ 21.8001
      (52.98%)
      		1.14M
      EGIOEdgio Inc
      $ 1.239
      (-79.92%)
      		4.72M
      PEGYPineapple Energy Inc
      $ 0.292758
      (-63.83%)
      		11.46M
      WHLRWheeler Real Estate Investment Trust Inc
      $ 6.6301
      (-35.32%)
      		9.35M
      HOVRNew Horizon Aircraft Ltd
      $ 0.70
      (-30.00%)
      		4.42M
      WTOUTime Limited
      $ 0.0469
      (-28.94%)
      		257.59M
      NVDANVIDIA Corporation
      $ 106.47
      (3.54%)
      		273.84M
      WTOUTime Limited
      $ 0.0469
      (-28.94%)
      		257.65M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.1633
      (14.60%)
      		229.46M
      SQQQProShares UltraPro Short QQQ
      $ 9.36
      (-3.70%)
      		169M
      INBSIntelligent Bio Solutions Inc
      $ 1.8199
      (15.18%)
      		90.84M

      CRNX Discussion

      View Posts
      FALCON1 FALCON1 1 month ago
      https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

      https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
      👍️0
      Monksdream Monksdream 2 months ago
      CRNX new 52 week high
      👍️0
      Monksdream Monksdream 6 months ago
      CRNX new 52 week high
      👍️0
      Monksdream Monksdream 12 months ago
      CRNX No 1 on the Barchart Top 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0

      Your Recent History

      NASDAQ
      CRNX
      Crinetics Pharmaceuticals
      Delayed Upgrade Clock